Zelnorm Side Effects & Recall Lawsuit

Send to Friend | Bookmark | Live Chat

Zelnorm (tegaserod maleate), a prescription medication used to treat "constipation predominant" Irritable Bowel Syndrome (IBS) has been removed/recalled from the U.S. market at the request of the U.S. Food & Drug Administration.

The Zelnorm recall was issued due to recent studies linking the drug to an increased risk of adverse cardiovascular events including Heart Attacks (myocardial infarction), Strokes (cerebrovascular accident) and Angina Pectoris.

In addition to serious cardiovascular injuries, our firm is also investigating other gastrointestinal injuries such as Intestinal Ischemia, Colonic Ischemia, Ischemic Colitis, Dead Bowel, Ulcerative Colitis and Chron's Disease.

What is the Problem?

The FDA has recently concluded that the benefits of taking Zelnorm no longer outweigh the risk. This finding was released after the drugs manufacturer submitted a new analysis of 29 short-term (1 - 3 months) randomized, controlled clinical trials of the drug showing an increased risk of serious cardiovascular adverse events (e.g., angina, heart attacks, and strokes) associated with use of Zelnorm.

FDA Recommendations

The FDA is advising patients taking Zelnorm to contact their physician to discuss alternative treatments for their condition and recommending that physicians should work with their patients to transition them to other therapies as appropriate to their symptoms and need.

IMPORTANT: patients who are taking Zelnorm should seek emergency medical care right away if they experience severe chest pain, shortness of breath, dizziness, sudden onset of weakness or difficulty walking or talking or other symptoms of a heart attack or stroke.

Our Experience - IBS Drug Litigation
Why You Should Choose Schmidt & Clark, LLP

“Our law firm has substantial expertise in the areas of gastrointestinal disorders such as IBS and the medications used to treat them."

Recently, the firm acted as lead counsel in the successful resolution of several hundred consumer claims involving the drug Lotronex® (alosetron), another IBS drug that was taken off the market because of serious side effects such as ischemic colitis (bleeding of the bowel) and bowel obstructions. Lotronex® was used to treat people with diarrhea-predominant IBS, but its pharmacology and mechanism of action is very similar to Zelnorm®. Both drugs act on a neurotransmitter substance called serotonin which effects numerous functions of the body, including “gut motility” (operation of the bowel), but also the brain and cardiovascular system.

Our attorneys are able to draw upon the pool of experience gained in Lotronex® and other products liability litigations to appropriately investigate, evaluate, and pursue potential Zelnorm® claims.

If you or a loved one have taken Zelnorm and suffered a serious cardiovascular or gastrointestinal side effect, you should contact us immediately. You may be entitled to compensation and we can help.

Types of Zelnorm Side Effects we are Investigating

• Ischemic Colitis (acute or chronic)
• Intestinal Ischemia and/or Colonic Ischemia
• Heart Attack
• Stroke
• Angina Pectoris
• Dead Bowel
• Ulcerative Colitis
• Chron's Disease
• Serious Cardiovascular Injuries
• Serious Gastrointestinal Injuries

Do I have a Zelnorm Lawsuit?

The Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus exclusively on the representation of plaintiffs in Zelnorm lawsuits. We are handling individual litigation nationwide and currently accepting new Zelnorm cases in all 50 states.

Attention Attorneys: We do not publish prior verdict/settlements. If you are an attorney and would like to refer us a case or for us to send you a profile of prior award judgments or average referral fees, please visit the attorney referral section of our website.

= Required Field

Zelnorm Recall, Side Effects & Lawsuit News (National)

Popular Anti-Constipation Drug Zelnorm Pulled from North American ... - Health Talk A popular and widely-prescribed medication used to relieve constipation in women has been pulled off the pharmacy shelves in the United States and Canada at the request of the U.S.-based FDA. The drug, manufactured by the Swiss-based pharmaceutical ...